ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
HilleVax Inc

HilleVax Inc (HLVX)

1.91
-0.06
(-3.05%)
Closed January 15 4:00PM
1.91
0.00
( 0.00% )
Pre Market: 4:04AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.91
Bid
1.91
Ask
2.05
Volume
-
0.00 Day's Range 0.00
1.55 52 Week Range 20.22
Market Cap
Previous Close
1.91
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
242,563
Shares Outstanding
49,806,070
Dividend Yield
-
PE Ratio
-0.77
Earnings Per Share (EPS)
-2.48
Revenue
-
Net Profit
-123.57M

About HilleVax Inc

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was $1.91. Over the last year, HilleVax shares have traded in a share price range of $ 1.55 to $ 20.22.

HilleVax currently has 49,806,070 shares outstanding. The market capitalization of HilleVax is $95.13 million. HilleVax has a price to earnings ratio (PE ratio) of -0.77.

HLVX Latest News

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...

HilleVax Announces Reduction in Force

BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.14-6.829268292682.052.081.9052758161.96852751CS
40.052.688172043011.862.151.833469351.9773492CS
120.042.139037433161.872.151.782425631.95314879CS
260.137.303370786521.782.151.583553251.8558891CS
52-12.72-86.944634313114.6320.221.554197884.1485204CS
156-16.85-89.818763326218.7624.421.552169357.2147817CS
260-16.85-89.818763326218.7624.421.552169357.2147817CS

HLVX - Frequently Asked Questions (FAQ)

What is the current HilleVax share price?
The current share price of HilleVax is $ 1.91
How many HilleVax shares are in issue?
HilleVax has 49,806,070 shares in issue
What is the market cap of HilleVax?
The market capitalisation of HilleVax is USD 95.13M
What is the 1 year trading range for HilleVax share price?
HilleVax has traded in the range of $ 1.55 to $ 20.22 during the past year
What is the PE ratio of HilleVax?
The price to earnings ratio of HilleVax is -0.77
What is the reporting currency for HilleVax?
HilleVax reports financial results in USD
What is the latest annual profit for HilleVax?
The latest annual profit of HilleVax is USD -123.57M
What is the registered address of HilleVax?
The registered address for HilleVax is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HilleVax website address?
The website address for HilleVax is www.hillevax.com
Which industry sector does HilleVax operate in?
HilleVax operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PMAXPowell Max Ltd
$ 2.94
(112.90%)
2.12M
CRWSCrown Crafts Inc
$ 6.79
(51.06%)
1
SOBRSOBR Safe Inc
$ 1.34
(50.56%)
13.81M
GEOSGeospace Technologies Corporation
$ 14.99
(47.83%)
1
PBHCPathfinder Bancorp Inc
$ 21.00
(32.83%)
4
IROQIF Bancorp Inc
$ 15.01
(-36.96%)
1
FXNCFirst National Corporation
$ 15.01
(-35.08%)
22
ABLAbacus Life Inc
$ 5.01
(-33.20%)
1
TBCHTurtle Beach Corporation
$ 13.01
(-30.98%)
3
HTLMHomesToLife Ltd
$ 5.70
(-28.75%)
203
BLRXBioLineRx Ltd
$ 0.1152
(10.13%)
23.84M
SOBRSOBR Safe Inc
$ 1.34
(50.56%)
13.81M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.2579
(11.02%)
5.17M
SHViShares Short Treasury Bond ETF
$ 110.29
(0.01%)
4.77M
RGTIRigetti Computing Inc
$ 11.20
(2.38%)
4.13M

Your Recent History

Delayed Upgrade Clock